Patients with CKD stages 3 and 4, without cerebrovascular disease, had elevated plasma concentrations of NfL, p-Tau231 and GFAP compared with healthy controls, and mGFR was inversely correlated to plasma levels of these biomarkers. Here, GFAP is linked to cerebrovascular disorder.